about
The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesiumEryptosis as a marker of Parkinson's diseaseTemporary dietary iron restriction affects the process of thrombus resolution in a rat model of deep vein thrombosis.Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease.Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.Cancer wars: significance of protein unfolding in cancer and its inhibition with natural amphiphilic substances.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence.Iron-induced parafibrin formation in tumors fosters immune evasion.Physiochemical basis of human degenerative disease.Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial.Application of Sodium Selenite in the Prevention and Treatment of Cancers.Effects of chronic exposure to mercury and cadmium alone and in combination on the coagulation system of Sprague-Dawley rats.Serum trace elements are associated with hemostasis, lipid spectrum and inflammatory markers in men suffering from acute ischemic stroke.Iron modulates the alpha chain of fibrinogen.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.
P2860
Q26859190-20B6E666-45AC-4CF6-A5BE-9B4D05499722Q34585744-DB7CA851-1DD6-4726-873C-31E7E58312BAQ35626991-7AE3EBB7-4564-41D0-98BE-250E5DA69623Q36546334-B4CBBD8A-1FFF-4BEC-849D-67E12146BEF6Q37369954-B7B4D1C7-9FA9-4B52-ACDE-6508171246F7Q38203153-F35905E3-6287-4201-B340-BFA3C3849C7BQ38234996-963D0885-5644-4954-85D2-5EF18E0A4ADAQ38261764-E0D083A0-6BD1-421F-8AB2-2D26F9BBD360Q38300645-0C4B34CB-EC40-434C-8957-BDE61CB87E61Q40877330-6BDD3878-F4F6-415E-844D-C0717CB59A07Q42142795-8D825F26-8451-4F56-B9A0-46A716344BF7Q47230788-D7CB3E30-EF36-4578-92AC-7E2B94496021Q47422547-D5D376C1-CD0F-4D84-903F-33C34FA31E32Q48004425-013B9601-6290-4BD6-AC84-DFBDD5CEC8C3Q48299834-E40632C0-920A-4D97-915A-5C2571F5C4F9Q53207527-9CFB7114-5FB6-433C-BAB3-D58DB4920AD5Q53698735-A2B8FB39-7E5E-4D77-9D5E-BEFF4B20C232
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Iron-induced fibrin in cardiovascular disease
@en
Iron-induced fibrin in cardiovascular disease.
@nl
type
label
Iron-induced fibrin in cardiovascular disease
@en
Iron-induced fibrin in cardiovascular disease.
@nl
prefLabel
Iron-induced fibrin in cardiovascular disease
@en
Iron-induced fibrin in cardiovascular disease.
@nl
P2860
P921
P1476
Iron-induced fibrin in cardiovascular disease
@en
P2093
Boguslaw Lipinski
P2860
P304
P356
10.2174/15672026113109990016
P577
2013-08-01T00:00:00Z